Upcoming Events
  1. TACT Board Teleconference (closed)

    August 28 - August 29
  2. ESMO 2017 Congress, Madrid Spain

    September 8 - September 12
  3. ***UPDATED*** 3rd ALTG Preceptorship in Lung Cancer, Melbourne VIC

    September 22 @ 12:00 pm - September 23 @ 5:00 pm UTC+10
  4. TACT General Assembly (closed), Yokohama Japan

    October 15
  5. 18th WCLC, Yokohama Japan

    October 15 - October 18

ALTG 13/003 Rekindle: testing an online resource to promote sexual wellbeing for both patients and their partners – H Dhillon

Studies have estimated that between 40-100% of cancer survivors experience negative sexual changes after treatment. Changes to sexuality can lead to psychological and emotional distress for not only survivors, but also their partners, impacting their long-term quality of life.  Rekindle is a phase 2 study developed at The University of Sydney in partnership with Cancer Council New South Wales and funding from Australian Research Council.  The program aims to test the feasibility of recruiting participants into an online resource to deliver therapy intended to address concerns about sexuality in both patients and partners after a cancer diagnosis.

The Rekindle trial closed to recruitment in November 2016 with 101 participants.  Nearly all participants have reached the end of their program duration and the analysis is about to commence. We hope to be presenting the feasibility results at ASCO 2017 and to publish our results soon after.

For information or to request materials, contact Dr. Haryana Dhillon, Principal Investigator, at haryana.dhillon@sydney.edu.au